Nomogram Based on Cytokines for Cardiovascular Diseases in Xinjiang Kazakhs

Abstract EN

Background.

This study involved the development of a predictive 5-year morbidity nomogram for cardiovascular diseases (CVD) in Xinjiang Kazakhs based on cytokine levels.

Methods.

The nomogram was based on a baseline survey of the town of Nalati in the Kazakh Autonomous Prefecture of Xinjiang from 2009 to 2013.

By 2016, we had monitored 1508 people for a median time of 5.17 years and identified CVD events in the study population by collecting case information from local hospitals.

The study population was divided into the training (n=1005) and validation cohorts (n=503) in a 2 : 1 ratio.

The area under the receiver operating characteristic curve (AUC) was used to verify the predictive accuracy of the nomogram.

The result was assessed in a validation cohort.

Results.

At the end of the study, the incidence of CVD in Xinjiang Kazakhs was found to be 11.28%.

We developed a new nomogram to predict the 5-year incidence of CVD based on age, interleukin-6 (IL-6), and adiponectin (APN) levels, diastolic blood pressure, and dyslipidemia.

The AUC for the predictive accuracy of the nomogram was 0.836 (95% confidence interval: 0.802–0.869), which was higher than that for IL-6 and APN.

These results were supported by validation studies.

Conclusions.

The nomogram model can more directly assess the risk of CVD in Kazakhs and can be used for CVD risk assessment.